Hypofractionated Radiotherapy for Anaplastic Thyroid Cancer: Systematic Review and Pooled Analysis
Anaplastic thyroid carcinoma (ATC) is associated with a poor prognosis due to aggressive tumor growth and high treatment resistance. Hypofractionated treatment concepts may be more effective and less time consuming compared to normofractionated radiotherapy (RT). In this retrospective study, we aim...
Main Authors: | Dmytro Oliinyk, Teresa Augustin, Viktoria Florentine Koehler, Josefine Rauch, Claus Belka, Christine Spitzweg, Lukas Käsmann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/9/2506 |
Similar Items
-
Clinical Outcome and Toxicity in the Treatment of Anaplastic Thyroid Cancer in Elderly Patients
by: Teresa Augustin, et al.
Published: (2020-10-01) -
Combinatorial hypofractionated radiotherapy and pembrolizumab in anaplastic thyroid cancer
by: Janice Ser Huey Tan, et al.
Published: (2024-02-01) -
Concurrent Boost with Adjuvant Breast Hypofractionated Radiotherapy and Toxicity Assessment
by: Mona M. Sayed, et al.
Published: (2015-01-01) -
Targeted Therapy for Anaplastic Thyroid Carcinoma: Advances and Management
by: Jiaqian Yuan, et al.
Published: (2022-12-01) -
Prognostic factors in radiotherapy of anaplastic thyroid carcinoma: a single center study over 31 years
by: Julia Jacob, et al.
Published: (2023-04-01)